According to leading data and analytics company GlobalData’s Clinical Trials Database, over the past 20 years trial activity ...

US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...

Medical Devices conference, held in Munich, Germany on 28-29 January, was filled with sessions that dug into the minutiae of ...

Paradigm Biopharmaceuticals has selected Advanced Clinical as the CRO to support its Phase III trial, PARA_OA_012, focused on ...

A study from the University of Birmingham has indicated that digoxin could be used to treat senior individuals with heart ...

The Clinical Trials Regulation requires all trials across the EU to be filed through the European Medicines Agency’s digital filing system.

Velocity Clinical Research has announced a collaboration with VCT to address the challenge of double enrolment of subjects in trials, ...

Gameto claims its Fertilo iPSC system can mature eggs outside the body using 80% fewer hormonal injections than typical methods.

MindMed has dosed the first subject in the Phase III Panorama study of MM120 ODT for the treatment of generalised anxiety ...

MSD said that its sotatercept steering committee called for the trial to end as patients are moved to the ongoing open-label ...

The EMA has approved the expansion of Greenwich LifeSciences’ Phase III FLAMINGO-01 breast cancer trial in Europe to add 11 new sites.

Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study.